Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2012
10/03/2012CN101291693B Novel use of il-1beta compounds
10/02/2012US8278422 Antibodies that specifically bind beta-like glycoprotein hormone polypeptides and heterodimers thereof
10/02/2012US8278348 Chondropsin-class antitumor V-atpase inhibitor compounds, compositions and methods of use thereof
10/02/2012US8278291 Treatment of wrinkles and strias with 4-hydroxyandrostenedione or a derivative thereof
10/02/2012US8278272 GLP-1, exendin-4, peptide analogs and uses thereof
10/02/2012US8278098 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
10/02/2012CA2546300C 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
10/02/2012CA2484192C Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
10/02/2012CA2453676C Thermotherapy via targeted delivery of nanoscale magnetic particles
10/02/2012CA2427477C Active variants of fgf with improved specificity
10/02/2012CA2321444C Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects
09/2012
09/27/2012WO2012129473A1 Gallium complexes, pharmaceutical compositions and methods of use
09/27/2012WO2012129222A1 Methods for improving bone health in infants using long chain polyunsaturated fatty acids
09/27/2012WO2012129220A1 Methods for improving bone health in infants using prebiotics
09/27/2012WO2012127885A1 Tetrahydrocarboline derivative
09/27/2012WO2012126901A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/27/2012WO2012126181A1 Use of kinase inhibitors in preventing and treating inflammatory disorder
09/27/2012WO2012104263A3 1,4 oxazines as bace1 and/or bace2 inhibitors
09/27/2012US20120245552 Combination Therapy
09/27/2012US20120245206 Multi-cyclic compounds and methods of use
09/27/2012US20120245202 Methods and products for treating inflammation
09/27/2012US20120245195 Novel monohydrate of azaadamantane derivatives
09/27/2012US20120245194 Small molecule inhibitors of the alpha4-paxillin interaction
09/27/2012US20120245175 Mk2 inhibitors
09/27/2012US20120245169 Certain chemical entities, compositions and methods
09/27/2012US20120245164 Diphenyl-pyrazolopyridine derivatives, preparation thereof, and use thereof as nuclear receptor not modulators
09/27/2012US20120245150 NOVEL (HETEROCYCLE/TETRAHYDROPYRIDINE)-(PIPERAZINYL)-1-ALCANONE AND (HETEROCYCLE/DIHYDROPYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS p75 INHIBITORS
09/27/2012US20120245149 NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS
09/27/2012US20120245148 Tetrahydroquinoxaline uera derivatives, their preparation and their therapeutic application
09/27/2012US20120245144 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/27/2012US20120245140 N-containing heteroaryl derivatives as jak3 kinase inhibitors
09/27/2012US20120245138 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides
09/27/2012US20120245135 Gallium Complexes, Pharmaceutical Compositions And Methods Of Use
09/27/2012US20120245134 Androgen pharmaceutical composition and method for treating depression
09/27/2012US20120245123 Methods for improving bone health in infants using prebiotics
09/27/2012US20120245122 Carotenoid-containing compositions and methods
09/27/2012US20120245121 Methods for improving bone health in infants using long chain polyunsaturated fatty acids
09/27/2012US20120245113 Clerodane derivatives for modulation of leukotriene receptor activity and related diseases
09/27/2012US20120245111 Flavanones-containing food compositions
09/27/2012US20120245110 Vascular leakage inhibitor
09/27/2012US20120245092 Polypeptides having modulatory effects on cells
09/27/2012US20120245091 Polypeptide or fused protein thereof inhibiting the extravasation of white blood cells or the growth and/or metastasis of cancer cells
09/27/2012US20120245088 Compositions comprising igf1 agonists and uses thereof
09/27/2012US20120245086 WNT10-Derived Peptide and Use Thereof
09/27/2012US20120245081 Fas peptide mimetics and uses thereof
09/27/2012US20120244232 Black bear parathyroid hormone and methods of using black bear parathyroid hormone
09/27/2012US20120244227 Biologically active food additive for the prophylaxis of osteoporosis disease
09/27/2012US20120244224 NANOSTRUCTURAL MATERIALS THAT INCREASE MINERALIZATION IN BONE CELLS AND AFFECT GENE EXPRESSION THROUGH miRNA REGULATION AND APPLICATIONS OF SAME
09/27/2012US20120244218 Calcium supplement
09/27/2012US20120244189 Treatment of infections
09/27/2012US20120244171 Cytotoxic benzodiazepine derivatives
09/27/2012US20120244147 Combination therapy of cancer with anti-endoglin antibodies and anti-vegf agents
09/27/2012US20120244139 Modified proteases that inhibit complement activation
09/27/2012US20120244128 Perivascular Stem Cell Composition For Bone
09/27/2012US20120244114 Antigen associated with rheumatoid arthritis
09/27/2012US20120244069 Human monoclonal antibodies against cd25
09/27/2012CA2829794A1 Methods for improving bone health in infants using long chain polyunsaturated fatty acids
09/27/2012CA2829598A1 Methods for improving bone health in infants using prebiotics
09/27/2012CA2825966A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/26/2012EP2502996A2 Anti-FGF23 antibody and pharmaceutical composition comprising the same
09/26/2012EP2502632A1 Preventative agent and/or therapeutic agent and/or exacerbation-suppressing agent for human knee osteoarthritis
09/26/2012EP2502507A1 Methods for improving bone health in infants using prebiotics
09/26/2012EP2502506A1 Methods for improving bone health in infants using long chain polyunsaturated fatty acids
09/26/2012EP2501705A1 2,4-pyrimidinediamine compounds and prodrugs thereof and their uses
09/26/2012EP2501669A2 Novel arylated camphenes, processes for their preparation and uses thereof
09/26/2012EP2501394A1 Use of eggshell membrane formulations to alleviate joint pain
09/26/2012EP2501387A2 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
09/26/2012CN102690353A Method for rapid screening of modified tumor necrosis factor receptor II-adiponectin globular-site fusion protein and application thereof
09/26/2012CN102690350A Anti-il-22ra antibodies and binding partners and methods of using in inflammation
09/26/2012CN102690278A Novel pyrimidine-fused cyclic compounds as cytokine inhibitors
09/26/2012CN102690234A Novel crystal forms of substituted phenylalkanoic acids and process for producing the same
09/26/2012CN102690221A 改性的拟赖氨酸化合物 Proposed modification of lysine compound
09/26/2012CN102688473A Externally applied medicine for treating bone fracture and preparation method thereof
09/26/2012CN102688459A Traditional Chinese medicine composite for curing cervical spondylosis and preparation method thereof
09/26/2012CN102688452A Chinese medicinal plaster for treating alcohol-induced osteonecrosis, and preparation method and application thereof
09/26/2012CN102688449A Chinese medicinal bath composition for treating bone injury, and application method thereof
09/26/2012CN102688425A Medicine for treating hyperosteogeny or intervertebral disc protrusion of cervical vertebra and lumbar vertebra
09/26/2012CN102688391A Traditional Chinese medicine (TCM) liquor for treating osteoporosis
09/26/2012CN102688388A Drug for treating fractures
09/26/2012CN102688367A Medicinal composition for treating hyperuricemia
09/26/2012CN102688363A Traditional Chinese medicine for treating rheumatic arthritis
09/26/2012CN102688340A Chinese medicine composition for treating gout
09/26/2012CN102688337A Medicinal liquor for regulating qi and blood
09/26/2012CN102688319A Medicine composition granule for removing stasis
09/26/2012CN102688294A Illicium henryi-contained anti-virus ointment for external use and preparation method and application thereof
09/26/2012CN102688277A Pharmaceutical composition and preparation for eliminating dampness and dredging obstruction as well as preparation and application for same
09/26/2012CN102688274A Solid dispersion of frankincense extract and preparation method thereof
09/26/2012CN102688269A External powder patch for treating hyperosteogeny
09/26/2012CN102688249A Medicinal composition containing strontium salt
09/26/2012CN102688221A Method for preparing aceclofenac enteric microcapsules
09/26/2012CN102688191A Medicine composition containing vitamin K1 and oil
09/26/2012CN102309373B Health-care physiotherapy bag for treating rheumatic disease and preparation method thereof
09/26/2012CN102228583B Chinese herbal composition and application thereof to preparing antirheumatic and antalgesic medicines
09/26/2012CN102218131B External Chinese herbal medicine composition for promoting tissue regeneration and knitting bones
09/26/2012CN102151307B Medicine for treating osteonecrosis resurrection and preparation method thereof
09/26/2012CN102115721B Lactobacillus isolated strains with anti-inflammatory activity and use thereof
09/26/2012CN102091043B Growth factor slow release microballoon and preparation method thereof
09/26/2012CN101612173B Glabrous sarcandra herb extract, quality control method for extract preparation and application of thereof
09/26/2012CN101282981B Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
09/25/2012US8273765 Bicyclo-pyrazoles and pharmaceutical compositions comprising them
1 ... 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 ... 820